Clearmind Medicine Shares Are Trading Higher After the Company Announced It Has Received Institutional Review Board Approval From One of Its Clinical Sites in the U.S. for Part A of Its Phase I/IIa Clinical Trial in the United States for Treating...

Clearmind Medicine股票上漲，因公司宣佈已經獲得美國一家臨床研究機構審批，用於其在美國進行的I/IIa期臨床試驗A部分治療...

Benzinga · 2024/10/10 20:15

Clearmind Medicine Shares Are Trading Higher After the Company Announced It Has Received Institutional Review Board Approval From One of Its Clinical Sites in the U.S. for Part A of Its Phase I/IIa Clinical Trial in the United States for Treating Patients Suffering From Alcohol Use Disorder.

Clearmind Medicine股票交易上漲，公司宣佈已經獲得美國一家臨床試驗點的機構審查委員會批准，用於治療酒精濫用障礙患者的I/IIa期臨床試驗A部分。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息